ARGX Chart
See on advanced chart >
About
argenx SE was incorporated on April 25, 2008, as a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) under Dutch law. On May 28, 2014, the company converted into a public company with limited liability (naamloze...
Read More
- HighlightA global immunology company that develops therapies to treat severe autoimmune diseases and cancer
- ExchangeNASDAQ
- Listing Date05/18/2017
- Established Date04/25/2008
- Full-time Employees1,148
- AddressLaarderhoogtweg 25 1101 EB Amsterdam the Netherlands
- Tel31-76-3030488
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Biotechnology